Other languages Interpace Biosciences, Inc.

Equities

IDXG

US46062X3035

Market Closed - OTC Markets Other stock markets 03:46:37 2024-04-29 pm EDT			5-day change	1st Jan Change
1.39 ^USD	-7.33%		-4.14%	+28.70%

Mar. 07	Earnings Flash (IDXG) INTERPACE BIOSCIENCES Reports Q4 Revenue $10.3M	MT
Mar. 07	Interpace Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Interpace Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 07
Interpace Biosciences, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Mar. 07
Robert Gorman Provides Notice to Interpace Biosciences, Inc. of His Resignation as A Director and as Chairman of the Board, Including as A Member of the Board?s Regulatory Compliance Committee	Dec. 12
Interpace Biosciences, Inc. Announces Resignation of Edward Chan as Class II Director	Nov. 16
Interpace Biosciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 08
Interpace Biosciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-09
Interpace Biosciences, Inc. Expects to Stop Offering Pancragen Test Due to CMS Decision to End Reimbursement as of July 17, 2023	23-06-05
Interpace Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-12
Interpace Biosciences, Inc. Appoints Christopher Mccarthy as Principal Financial Officer	23-04-25
Interpace Biosciences, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022	23-03-27
Interpace Biosciences, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	23-03-27
Interpace Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-27
Interpace Biosciences, Inc. Auditor Raises 'Going Concern' Doubt	23-03-26
Interpace Biosciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-14
Interpace Biosciences, Inc. Announces New Clinical Validation Data	22-09-01
Flagship Biosciences, Inc. acquired Interpace Pharma Solutions from Interpace Biosciences, Inc..	22-08-30
Interpace Biosciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-15
Earnings Flash (IDXG) INTERPACE BIOSCIENCES Posts Q2 Revenue $9.4M	22-08-15
Interpace Biosciences, Inc. Announces New Clinical Validation Data for Thyroid Cancer Test Platform Published Online Within Thyroid®, the Leading Peer-Reviewed Journal for Original Research on Thyroid Cancer	22-08-15
Earnings Flash (IDXG) INTERPACE BIOSCIENCES Posts Q1 Revenue $10.4M	22-05-16

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Interpace Biosciences, Inc.

Equities

IDXG

US46062X3035

Other languages

Filters